CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tasly Pharmaceutical Group Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tasly Pharmaceutical Group Co Ltd
Tasly Modern TCM Building
No. 2, Pujihe East Road
Phone: +86 2226736999p:+86 2226736999 TIANJIN, TNJ  300410  China Ticker: 600535600535
Business Summary
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board KaijingYan 45 4/27/2015 4/27/2015
Vice Chairman of the Board XiaomengJiang 59 12/16/2008 12/16/2008
Vice Chairman of the Board HeSun 64 4/18/2018 4/18/2018
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Tasly Biopharmaceuticals Co Ltd No. 280 Juli Road SHANGHAI SHA China

Business Names
Business Name
600535
Shanghai Tasly Pharmaceutical Co Ltd.
Tianjin Tasly Pharmaceutical Co., Ltd.

General Information
Number of Employees: 9,223 (As of 12/31/2023)
Outstanding Shares: 1,493,950,005 (As of 2/20/2024)
Shareholders: 60,859
Stock Exchange: SHA
Fax Number: +86 2226736721


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024